Data from Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
Authors:
- Jesus D. Gonzalez-LugoJGJesus D. Gonzalez-Lugo
- Suman KambhampatiSKSuman Kambhampati
- Abdulraheem YacoubAYAbdulraheem Yacoub
- William B. DonnellanWDWilliam B. Donnellan
- Jesus BerdejaJBJesus Berdeja
- Prafulla BhagatPBPrafulla Bhagat
- Karen FehnKFKaren Fehn
- Cassady RemyCRCassady Remy
- Sakshi JasraSJSakshi Jasra
- Mohammed KazemiMKMohammed Kazemi
- Kith PradhanKPKith Pradhan
- Mimi KimMKMimi Kim
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)